The total return over the past 12 months is -92.54% vs. +16.94% for the S&P 500. So far it's up -77.56% this year. Includes price appreciation + reinvested dividends.
| Category | 1Y (TTM) | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Price CAGR | (92.54%) | (32.06%) | (44.41%) | N/A | N/A | N/A |
| Total Return CAGR | (92.54%) | (12.94%) | (35.49%) | N/A | N/A | N/A |
| Revenue CAGR | +329.50% | N/A | N/A | N/A | N/A | N/A |
| Net Income CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| EPS CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Free Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Operating Cash Flow CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
| Dividends CAGR | N/A | N/A | N/A | N/A | N/A | N/A |
Visualize historical growth rates over rolling horizons. Use the dropdown to select different metric vectors.
LENZ Therapeutics, Inc. (LENZ)
| Year | Start price | End price | LENZ Return | SPY Return | Outperformance |
|---|---|---|---|---|---|
| 2026(YTD) | $16.00 | $3.59 | (77.56%) | +14.51% | (92.07%) |
| 2025 | $28.87 | $16.00 | (44.58%) | +17.72% | (62.30%) |
| 2024 | $12.40 | $28.87 | +389.87% | +24.89% | +364.98% |
| 2023 | $15.71 | $12.40 | (21.07%) | +26.19% | (47.26%) |
| 2022 | $58.83 | $15.71 | (73.30%) | (18.17%) | (55.13%) |
Start and end prices are split-adjusted closing prices. Total return includes reinvested dividends, so it can differ from the price change.
